Skip to content

Addiction: all studies

Page 399 of 855: studies 3,981 to 3,990 of 8,547, newest first. Back to the addiction overview

Research

No prescription? No problem: A qualitative study investigating self-medication with novel psychoactive substances (NPS).

International Journal of Drug Policy August 1, 2023 Tayler Holborn, Fabrizio Schifano, Paolo Deluca 15 citations

The proliferation of Novel Psychoactive Substances (NPS) presents a challenge for global drug policy. The ease of online drug purchase and the emergence of the dark web have created new avenues for the growth of NPS. Despite the global nature of this issue, limited research has examined motivations of use. These include perceived safety or convenience, an interest in novel pharmacology and...

The impact of interoceptive accuracy and stimulation type on the out-of-body experience.

Quarterly Journal of Experimental Psychology August 1, 2023 Ke Ma, Liping Yang, Bernhard Hommel 4 citations

People tend to perceive a virtual body standing in front of them as their own if it is either stroked or moving synchronously with their own real body-the out-of-body experience (OBE). We combined synchrony manipulation with two other factors of theoretical interest: the kind of stimulation, visuotactile stimuli or visuomotor correlations, being synchronised and the interoceptive accuracy (IA)...

DOI: 10.1177/17470218221128285 (opens in new tab) Full text (opens in new tab) Sense of ownership Interoceptive accuracy Out-of-body experiences Self-location

5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.

Neuropsychopharmacology August 1, 2023 Sarah J. Jefferson, Ian Gregg, Mark Dibbs et al. 57 citations

Serotonergic psychedelics are gaining increasing interest as potential therapeutics for a range of mental illnesses. Compounds with short-lived subjective effects may be clinically useful because dosing time would be reduced, which may improve patient access. One short-acting psychedelic is 5-MeO-DMT, which has been associated with improvement in depression and anxiety symptoms in early phase...

DREAMWORK AS A COMPONENT OF POST-TRAUMATIC REHABILITATION OF COMBATANTS SYMBOLIZATION OF COMBATANTS’ MARGINALIZATION IN DREAMS

PSYCHOLOGICAL JOURNAL July 31, 2023 Taras Novytskyi, Halyna Katolyk

Post-traumatic stress disorder(further – PTSD) is a complex and multi-faceted psychic phenomenon, which is in need of rigorous research. The number of studies done on PTSD is vast, and the number of its treatments – starting with evidence-based exposure therapy and medication and ending with experimental treatments like transcranial magnet stimulation and psychoactive substance use – are very...

Noribogaine effects on wakefulness and sleep

bioRxiv (Cold Spring Harbor Laboratory) July 28, 2023 Juan Pedro Castro-Nin, Diego Serantes, Paola Rodrı́guez et al. 1 citation preprint

Abstract Ibogaine is a potent atypical psychedelic that has gained considerable attention due to its antiaddictive and antidepressant properties in preclinical and clinical studies. Previous research from our group showed that ibogaine suppresses sleep and produces an altered wakefulness state which resembles natural REM sleep. However, after systemic administration, ibogaine is rapidly...

DOI: 10.1101/2023.07.26.550725 (opens in new tab) Full text (opens in new tab) Wakefulness Sleep system call Slow-wave sleep Antidepressant +3

How the Mind Creates the Body and What Can Go Wrong: Case Studies of Misperceptions of the Body

Healthcare July 27, 2023 Erich Kasten, Jill Julia Eilers 5 citations

The review brings together a wealth of case studies, both from the authors' patients and from the literature, about people whose bodies do not feel as they really should. Body parts suddenly become longer or shorter, heavier or lighter and there may be a loss of body control to the point where individuals feel as if they no longer have a body at all. The article differentiates by type of...

Can Computational Intelligence Model Phenomenal Consciousness?

Philosophies July 27, 2023 Eduardo C. Garrido-Merchán, Sara Lumbreras 3 citations

Consciousness and intelligence are properties that can be misunderstood as necessarily dependent. The term artificial intelligence and the kind of problems it managed to solve in recent years has been shown as an argument to establish that machines experience some sort of consciousness. Following Russell’s analogy, if a machine can do what a conscious human being does, the likelihood that the...

Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz

Psychiatric News July 27, 2023 Terri D’arrigo 1 citation

Back to table of contents Previous article Next article Med CheckFull AccessMed Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and LumryzTerri D’ArrigoTerri D’ArrigoSearch for more papers by this authorPublished Online:27 Jul 2023https://doi.org/10.1176/appi.pn.2023.08.8.3FDA Expedites Review of Anti-Amyloid Beta Vaccine for Alzheimer’s DiseaseThe Food and Drug...

Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial

Cannabis and Cannabinoid Research July 26, 2023 Valentina Lorenzetti, Eugene McTavish, Samantha J Broyd et al.

Introduction: Cannabis use is associated with brain functional changes in regions implicated in prominent neuroscientific theories of addiction. Emerging evidence suggests that cannabidiol (CBD) is neuroprotective and may reverse structural brain changes associated with prolonged heavy cannabis use. In this study, we examine how an ∼10-week exposure of CBD in cannabis users affected...